5/2
Penn Bioethicists Call for End to "Pay-to-Play" Clinical Research
Charging people to participate in research studies is likely to undermine the fundamental ethical basis of clinical research, according to a new paper written by bioethicists, including lead author Ezekiel Emanuel, MD, PhD, chair of the department of Medical Ethics and Health Policy at the Perelman School of Medicine
Penn Medicine Study Finds Participation in Research Studies Not Detrimental to Preterm Infants
Premature babies who are enrolled in clinical trials for therapies to treat and prevent complications from preterm birth are no more likely to die or experience poor outcomes than babies who are not trial participants, according to a retrospective analysis of more than 5,000 babies born before 29 weeks of gestation.
Penn Study Shows Nearly 10 Percent of Women Live Too Far from Access to Gynecologic Cancer Care
More than one-third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 million women.
Penn Medicine Study Shows First Signs that Drug Used to Treat ADHD May Improve Cognitive Difficulties for Menopausal Women
According to a new study, women experiencing difficulty with time management, attention, organization, memory, and problem solving – often referred to as executive functions – related to menopause may find improvement with a drug already being used to treat attention deficit hyperactivity disorder (ADHD).
Penn Medicine Study Reveals Novel Use of 3-D Imaging Technique for Precise Measurement of Injectable Wrinkle Reducers
A three-dimensional imaging technique often used in the automotive and aerospace industries for accurate measurement may be useful to measure the efficacy of injectable wrinkle reducers such as Botox and Dysport, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
Penn Medicine Authors Emphasize Importance of Clinically Actionable Results in Genetic Panel Testing for Breast Cancer
While advances in technology have made multigene testing, or “panel testing,” for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in orde
Most Women are Unaware of New Guidelines for Pap Test Frequency, Penn Medicine Study Reveals
Women know that Pap tests are a useful screening test for cervical cancer, but according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania, most of those surveyed are unaware of the updated screening guidelines for the appropriate frequency of Pap tests in low-risk women.
Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening
Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the
Female Cystic Fibrosis Patients Need More Contraceptive Guidance, Penn Medicine Study Finds
nly half of women with cystic fibrosis (CF) report using contraception and frequently apt to become pregnant unintentionally, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Penn Study Shows Risk of Breast and Ovarian Cancer May Differ By Type of BRCA1, BRCA2 Mutation
In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at the Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the University of Pennsylvania, identified mutations that are associated with significantly different risks of breast and ovarian cancers.